SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-030496
Filing Date
2024-03-13
Accepted
2024-03-13 07:00:12
Documents
15
Period of Report
2024-03-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rnlx-20240312.htm   iXBRL 8-K 57466
2 EX-10.1 rnlx-ex10_1.htm EX-10.1 699707
3 EX-99.1 rnlx-ex99_1.htm EX-99.1 256136
4 EX-99.2 rnlx-ex99_2.htm EX-99.2 48040
  Complete submission text file 0000950170-24-030496.txt   1376633

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rnlx-20240312.xsd EX-101.SCH 52658
17 EXTRACTED XBRL INSTANCE DOCUMENT rnlx-20240312_htm.xml XML 6091
Mailing Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE
Business Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE 44 29 2071 0570
Renalytix plc (Filer) CIK: 0001811115 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39387 | Film No.: 24744534
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)